Eurocine Vaccines is publically listed at Spotlight Stock Market XSAT, Sweden, with the ticker EUCI.

To be notified with news, sign up to our newsfeed =>

Legal Advisor is Lindahl.

Sedermera is our Financial Advisor.

Patent and Intellectual Property (IP) advisors are Zacco and Potter Clarkson.

Eurocine Vaccines preferential share issue October 2022

All documentation in Swedish – subscriptions forms also in English

Eurocine Vaccines´ board of directors has decided, with the support of the authorization from the AGM on 21 December 2021, to carry out a fully guaranteed preferential share issue, with subscription period 4 – 18 October 2022. The company has published an Information Memorandum (below) which contains complete conditions and instructions.

Subscription forms and a Summary Teaser are available below.

Nordic Issuing’s website ( also offers the option to subscribe for shares via digital signature.

Eurocine Vaccines Memorandum 2022-09-27

Eurocine Vaccines Teaser

Pressmeddelandet med Emissionsbeslutet 2022-09-21

Anmälningssedel med teckningsrätter

Anmälningssedel utan teckningsrätter

Subscription form with subscription rights

Subscription form without subscription rights

Latest Investor Presentation
CEO Dr. Hans Arwidsson presents at Småbolagsdagarna, 15 juni 2022

Future Financial Reports

The Interim Report July – September 2022 is planned to be available 29 November 2022.

The Annual Report 2021 – 2022 is planned to be available 29 November 2022.

Existing Financial Reports

Full Year Report July 2021 – June 2022 =>

Interim Report July 2021 – March 2022 =>

Interim Report July – December 2021 =>

Interim Report July – September 2021 =>

Full Year Report July 2020 – June 2021 =>

Interim Report July 2020 – March 2021 =>

Half Year Report July – December 2020 =>

Interim Report July – September 2020 =>